Yuan Li

11PUBLICATIONS
2CO-AUTHORS
Molecular targetsPredictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 09, 2026
ITGB4 up-regulated by STAT3 reduces the sensitivity of bladder cancer to cisplatin by suppressing p53.

Zhuo Xing, Haozhe Xu, Pingxia Lin

|Apr 17, 2025
The prognostic value of CXCR4 PET/CT imaging in unilateral primary aldosteronism patients after adrenalectomy.

Shuai Shao, Haozhe Xu, Zhuo Xing

|Jul 10, 2024
ASO Author Reflections: Accurate and User-Friendly Models for Predicting Oncologic Outcomes Following Partial Nephrectomy in Patients with cT1-ccRCC.

Haozhe Xu, Yuan Li

|Jul 06, 2024
Development and External Validation of Nomograms for Predicting Disease-Free Survival and Overall Survival in Patients with cT1-ccRCC After Partial Nephrectomy: A Multicenter Retrospective Study.

Haozhe Xu, Zhuo Xing, Jie Wang

|Feb 08, 2024
Gross Hematuria Does not Affect the Selection of Nephrectomy Types for Clinical Stage 1 Clear Cell Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study.

Zhuo Xing, Haozhe Xu, Kai Ai

|Feb 06, 2024
ASO Author Reflections: Clinical Stage I Clear Cell Renal Cell Carcinoma Patients with Gross Hematuria: Radical Nephrectomy or Partial Nephrectomy?

Zhuo Xing, Yuan Li

Pageof 2

Frequent Collaborators

1 joint publications

Haozhe Xu

1 joint publications

Yongbao Wei